Kenneth Ssebambulidde, MBChB, MSc
Hospital ResidentCards
About
Research
Publications
2026
Central Nervous System Toxoplasmosis is an Under‐Recognized Opportunistic infection in Uganda
Bahr NC, Kasibante J, Nsangi L, Kagimu E, Ssebambulidde K, Rutakingirwa MK, Tugume L, Ramachandran PS, Cresswell F, Meya DB, Boulware DR, Wilson MR, Ellis J. Central Nervous System Toxoplasmosis is an Under‐Recognized Opportunistic infection in Uganda. Journal Of Tropical Medicine 2026, 2026: 2158978. DOI: 10.1155/jotm/2158978.Peer-Reviewed Original ResearchGLP-1 receptor agonists and clinical outcomes in adults with Crohn’s disease and obesity: a propensity score–matched real-world cohort study
Ganju N, Ssebambulidde K, Gupta S, Adidam SR, Michael M, Kibreab A, Aduli F. GLP-1 receptor agonists and clinical outcomes in adults with Crohn’s disease and obesity: a propensity score–matched real-world cohort study. Scientific Reports 2026 DOI: 10.1038/s41598-026-58181-y.Peer-Reviewed Original Research
2025
Correlates of HIV pre- and post-exposure prophylaxis uptake among female university students in Uganda
Segawa I, Bakeera-Kitaka S, Oriokot L, Ssebambulidde K, Muwonge T, Ojiambo K, Mujugira A. Correlates of HIV pre- and post-exposure prophylaxis uptake among female university students in Uganda. African Journal Of AIDS Research 2025, 24: 197-204. PMID: 41031422, DOI: 10.2989/16085906.2025.2555200.Peer-Reviewed Original ResearchCerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-Week and 1-Year Survival Among Persons With HIV-Associated Cryptococcal Meningitis
Rutakingirwa M, Ssebambulidde K, Okurut S, Kwizera R, Nabwana M, Gakuru J, Ndyetukira J, Mulwana S, Nankungu L, Tadeo K, Musubire A, Boulware D, Meya D. Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-Week and 1-Year Survival Among Persons With HIV-Associated Cryptococcal Meningitis. Journal Of Infectious Diseases 2025, 232: 1088-1096. PMID: 40839770, PMCID: PMC12614965, DOI: 10.1093/infdis/jiaf449.Peer-Reviewed Original ResearchCerebral Perfusion Pressures and Implications on Clinical Outcomes and Medical Management in Cryptococcal Meningitis
Abassi M, Hou C, Fieberg A, Dai B, Musubire A, Robertson J, Tugume L, Ssebambulidde K, Nuwagira E, Muzoora C, Williams D, Boulware D, Meya D, Mpoza E, Kiggundu R, Pastick K, Ssebambulidde K, Akampurira A, Williams D, Bangdiwala A, Musubire A, Nicol M, Ahimbisibwe C, Kugonza F, Namuju C, Tadeo K, Kirumira P, Okirwoth M, Luggya T, Kaboggoza J, Laker E, Walukaga S, Evans E, Stadelman A, Flynn A, Fujita A, Kwizera R, Lofgren S, Cresswell F, Morawski B. Cerebral Perfusion Pressures and Implications on Clinical Outcomes and Medical Management in Cryptococcal Meningitis. Open Forum Infectious Diseases 2025, 12: ofaf451. PMID: 40832594, PMCID: PMC12359033, DOI: 10.1093/ofid/ofaf451.Peer-Reviewed Original ResearchPathway-instructed therapeutic selection of ruxolitinib reduces neuroinflammation in fungal postinfectious inflammatory syndrome
Hargarten J, Ssebambulidde K, Anjum S, Vaughan M, Xu J, Ganguly A, Dulek B, Otaizo-Carrasquero F, Song B, Tao S, Park Y, Scott T, Höltermann T, Schinazi R, Chittiboina P, Billioux B, Hammoud D, Olszewski M, Williamson P. Pathway-instructed therapeutic selection of ruxolitinib reduces neuroinflammation in fungal postinfectious inflammatory syndrome. Science Advances 2025, 11: eadi9885. PMID: 40117367, PMCID: PMC11927619, DOI: 10.1126/sciadv.adi9885.Peer-Reviewed Original ResearchImpact of cerebrospinal fluid leukocyte infiltration and activated neuroimmune mediators on survival with HIV-associated cryptococcal meningitis
Okurut S, Boulware D, Manabe Y, Tugume L, Skipper C, Ssebambulidde K, Rhein J, Musubire A, Akampurira A, Okafor E, Olobo J, Janoff E, Meya D, Team F. Impact of cerebrospinal fluid leukocyte infiltration and activated neuroimmune mediators on survival with HIV-associated cryptococcal meningitis. PLOS Neglected Tropical Diseases 2025, 19: e0012873. PMID: 39928682, PMCID: PMC11844869, DOI: 10.1371/journal.pntd.0012873.Peer-Reviewed Original ResearchNeurocognitive Impairment Among Cryptococcal Meningitis Survivors in Uganda, a Prospective Cohort Study
Nsangi L, Hullsiek K, Dai B, Namudde A, Menya G, Ssebambulidde K, Tugume L, Nuwagira E, Rhein J, Williams D, Musubire A, Boulware D, Meya D, Abassi M. Neurocognitive Impairment Among Cryptococcal Meningitis Survivors in Uganda, a Prospective Cohort Study. Open Forum Infectious Diseases 2025, 12: ofaf054. PMID: 40008306, PMCID: PMC11850114, DOI: 10.1093/ofid/ofaf054.Peer-Reviewed Original Research
2024
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022
Walukaga S, Fieberg A, Musubire A, Tugume L, Ssebambulidde K, Kagimu E, Kasibante J, Rutakingirwa M, Mpoza E, Gakuru J, Akampurira A, Jjunju S, Mwesigye J, Muzoora C, Nuwagira E, Bangdiwala A, Williams D, Rhein J, Meya D, Boulware D, Hullsiek K, Rajasingham R, Ndyetukira J, Ahimbisibwe C, Kugonza F, Namuju C, Sadiq A, Namudde A, Mwesigye J, Cresswell F, Kandole T, Kirumira P, Okirwoth M, Luggya T, Kwizera R, Mukaremera L, Lofgren S, Stadelman A, Morawski B, Rolfes M, Wiesner D, Najjuka G, Nanteza C, Mushagara R, Bahr N, Namawejje M, Ssennono M, Kiragga A, Taseera K, Nabeta H. The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022. Medical Mycology 2024, 63: myae115. PMID: 39779301, PMCID: PMC11718514, DOI: 10.1093/mmy/myae115.Peer-Reviewed Original ResearchClinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in Uganda
Kasibante J, Irfanullah E, Wele A, Okafor E, Ssebambulidde K, Okurut S, Kagimu E, Gakuru J, Rutakingirwa M, Mugabi T, Nuwagira E, Jjunju S, Mpoza E, Tugume L, Nsangi L, Musibire A, Muzoora C, Rhein J, Meya D, Boulware D, Abassi M. Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in Uganda. Medical Mycology 2024, 62: myae101. PMID: 39419774, PMCID: PMC11520412, DOI: 10.1093/mmy/myae101.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Get In Touch
Contacts
Mailing Address
Yale School of Medicine
20 York Street
New Haven, CT 06510-3220
United States